Andhra Petrochemicals Ltd

NSE: ANDHRAPET BSE: 500012

₹43.88

(1.10%)

Tue, 07 Jul 2026, 07:34 am

MTF 5xInvest in Andhra Petrochemicals Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)375.74

PE Ratio0

Dividend0

Process Industries

Chemicals: Specialty

24.5K

Andhra Petrochemicals News

Andhra Petrochemicals Swings to Profit in Q4

Andhra Petrochemicals reports Q4 net profit of 14M rupees vs a loss of 153M YoY, with EBITDA turning positive at 10M rupees despite a revenue decline.

27 May 2026

companies

Andhra Petrochemicals Board Meet Set for May 27, 2026

Andhra Petrochemicals schedules a Board meeting on May 27, 2026, to approve audited financial results for Q4 and full year ended March 31, 2026.

13 May 2026

companies

Andhra Petrochemicals Suspends Plant Operations

The Andhra Petrochemicals Limited has suspended operations at its Visakhapatnam plant from March 17, 2026, due to disruption in propylene supply from HPCL amid ongoing geopolitical tensions.

17 Mar 2026

companies

Andhra Petrochemicals Credit Rating Downgraded by ICRA

ICRA downgrades Andhra Petrochemicals' long-term credit facilities from A- to BBB+ with negative outlook, affecting Rs.92.18 crores of total facilities while reaffirming short-term rating.

09 Feb 2026

stocks

Andhra Petrochemicals Q3FY26 Loss Widens to ₹1077.28 Lakhs

Andhra Petrochemicals reported a net loss of ₹1077.28 lakhs for Q3FY26 versus ₹1515.46 lakhs loss in Q3FY25. Revenue declined to ₹6738.68 lakhs from ₹12452.89 lakhs year-on-year.

04 Feb 2026

co actions results

Showing 1–5 of 17

Rows per page:

Market Current News

SEBI Approves Rentomojo Ltd's IPO

SEBI has granted approval for Rentomojo Ltd's Initial Public Offering, marking a key regulatory milestone for the company's planned market debut.

06 Jul 2026

ipo

Concord Biotech Limited

Concord Biotech to hold 41st AGM on July 31

Concord Biotech Limited has scheduled its 41st Annual General Meeting for July 31, 2026, via video conferencing. The company has received a notice proposing the appointment of Mrs. Ekta Gupta as a Director.

06 Jul 2026

ipo

GUJARAT KIDNEY AND SUPER SPECI

Gujarat Kidney approves IPO proceeds variation

Shareholders approved the variation in the objects and terms of utilisation of the IPO proceeds. The resolution received 99.9995% votes in favour.

06 Jul 2026

ipo

SEBI Approves Manipal Health Enterprises IPO

SEBI has granted approval for Manipal Health Enterprises to proceed with its initial public offering, marking a significant milestone for the healthcare company.

06 Jul 2026

ipo

NSE Seeks RBI Nod for Quanto Cross Currency Derivatives

NSE has requested RBI approval to introduce Quanto Cross Currency Derivatives, aiming to boost exchange-traded currency volumes in India.

06 Jul 2026

currency

Showing 1–5 of 93967

Rows per page: